2.54MMarket Cap-11P/E (TTM)
0.720High0.680Low172.52KVolume0.688Open0.680Pre Close120.64KTurnover4.81%Turnover RatioLossP/E (Static)3.59MShares84.96852wk High0.21P/B2.53MFloat Cap0.67052wk Low--Dividend TTM3.59MShs Float3911.600Historical High--Div YieldTTM5.88%Amplitude0.670Historical Low0.699Avg Price1Lot Size
Aptevo Therapeutics Stock Forum
Wow just brutal! But a buy opportunity possibly!
NEWS
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering
News
Benzinga· 1 min ago
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now successfully transitioned to a higher dose level, accessing the potential for greater clinical benefit in the ALG.APV-527 clinical trial
Cohort 5 dosing imminent, trial more than 50% enrolled
APVO436 Phase 1b/2 dose ...
It has arrived
Top stocks today:
$Aptevo Therapeutics(APVO.US)$
$Intrusion(INTZ.US)$
$Genius Group(GNS.US)$
Last time it closed at a new low it ran up about 45%.
Therapeutics Company Announces Positive Data For Solid Tumor Cancer
In a promising development for cancer research, Alligator Bioscience (Alligator) and Aptevo Therapeutics (Aptevo) have announced positive interim data from the dose escalation phase of their ALG.APV-527 Phase 1 study. The study focuses on patients with solid tumor cancers that express the tumor antige...
No comment yet